Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-cycloserine Augmentation of CBT in Depression
NCT02376257Phase 2Completed
- Start
- Sep 2014
- Primary completion
- Apr 2017
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of d-cycloserine in major depressive disorder (MDD). Started Sep 2014; status: completed.
02
Drugs
d-cycloserine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02376257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02376257.